Navigation Links
LaVoie Group Appointed by Mithridion as PR Agency
Date:5/4/2009

SALEM, Mass., May 4 /PRNewswire/ -- LaVoie Group, a life science-focused strategic communications agency, announced today that it has added Mithridion, Inc. to its life sciences agency client roster.

Donna L. LaVoie, President & CEO of LaVoie Group, commented, "We are delighted to be working on the leading edge of the life sciences sector. As a pioneer in the development of therapeutics for complex central nervous system disorders, Mithridion's strategy is a combination of partnerships and proprietary pipeline development. We look forward to representing them as the company moves its pipeline forward."

Trevor M. Twose, Chief Executive Officer of Mithridion, commented, "We selected LaVoie Group because of their in-depth expertise in the life sciences sector, and their creative, results-orientated ideas. LaVoie Group is a natural fit to help us become a more established brand in the CNS space."

About Mithridion, Inc.

Mithridion, Inc. is a biopharmaceutical company that discovers and develops drugs for central nervous system (CNS) disorders, with an initial focus on Alzheimer's disease and schizophrenia. Through the company's research and development efforts, as well as its merger with Cognitive Pharmaceuticals Ltd. in June 2008, Mithridion is developing a pipeline of CNS drug candidates. MCD-386, the company's lead candidate, is in a Phase I clinical trial for AD. Through Mithridion's effective clinical execution, the company was able to advance MCD-386 to initial clinical results within nine months of the merger with Cognitive Pharmaceuticals. Mithridion has raised $7.4 million of angel and venture funding to date. For more information, please visit, http://www.mithridion.com.

About LaVoie Group, Inc.

LaVoie Group provides senior-level strategic counsel and tactical implementation of venture, investor and public relations programs designed to properly position, create visibility and drive value for each client. We help our life sciences companies attract capital, reach corporate partners, generate revenue and build their companies through integrated communications programs. Our clients range from privately held start-ups to industry leaders in life sciences such as Vertex Pharmaceuticals, ESBATech AG, and Agile Therapeutics.

In March 2009, LaVoie Group was awarded the coveted 2008 Impact Award for "Best Industry-Exclusive Agency," sponsored by the League of American Communications Professionals (LACP). LaVoie Group is ranked by O'Dwyer's PR Report as one of the leading independent healthcare PR firms in the U.S. For more information, please visit http://www.lavoiegroup.com.


'/>"/>
SOURCE LaVoie Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster
2. LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster
3. LaVoie Group Adds Two New Companies to Its Life Science Client Roster
4. AMERIGROUP Corporation to Webcast Annual Meeting of Stockholders on May 7, 2009
5. AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share
6. Current Health Medical Group Makes House Calls to Combat Swine Flu Epidemic
7. The Ensign Group Schedules First Quarter 2009 Earnings Call for Thursday, May 7, 2009
8. Prospero Group (PRPG) and Fincor (FINC) Made a Share Transfer and Enter the Market with ACTRx a New Malaria and Dengue Fever Treatment
9. International Coal Group Is Lead Sponsor for West Virginia Susan G. Komen Race For The Cure
10. Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for Americas Health
11. Top Policy Groups Take Action to Create Healthy Communities, Prevent Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology: